Healthcare and Life Sciences

Format: 2017-02-23
Format: 2017-02-23
February 13, 2017 | 91 Pages | SKU: IRTNTR11351

Overview of the lifestyle drugs market

According to the market research analysts at Technavio, the global lifestyle drugs market will witness steady growth and will post a moderate CAGR of close to 3% over the forecast period. With the development of novel therapeutics, the market for lifestyle drugs is anticipated to have positive outlook over the coming years. As the market for depression are associated with high unmet medical needs, the need for novel therapeutics is on the rise, for instance, only 50% of individuals with depression receive any form of therapy. Out of these, only 25% of individuals receive a proper antidepressant dose and duration of treatment. Moreover, there are high unmet medical needs for erectile dysfunction. This has led the vendors to focus on developing novel therapeutics to increase the adoption rates for lifestyle drugs in the market.

The lifestyle drugs market is witnessing a sharp increase in mergers and acquisitions among the vendors which is one of the important trends gaining significant traction in the market. The vendors are pursuing inorganic growth strategies such as acquisitions and partnerships to expand their lifestyle drugs portfolio and to significantly improve their overall market presence. For example, in August 2015, Allergan completed the acquisition of Naurex. The acquisition enhanced Allergan’s portfolio of depression drugs with the addition of rapastinel. Such initiatives will contribute to the growth of the lifestyle drugs market over the next four years.

Competitive landscape and key vendors

The global lifestyle drugs market is highly fragmented with the presence of several key vendors such as Allergen


February 10, 2017 | 86 Pages | SKU: IRTNTR10761

Overview of the global blood glucose monitoring (BGM) devices market

The global blood glucose monitoring (BGM) devices market is anticipated to grow at a moderate rate and will post a CAGR of close to 12% during the forecast period. One of the growth drivers for the global BGM device market is the availability of reimbursement options for glucose meters. Generally, it has been noted that glucose meter devices must be replaced within six to eight months and are very expensive. As a result, most people prefer selecting health insurance plans that cover almost 80% of the total expenditure on healthcare devices. Such schemes also cover the cost of diabetes testing supplies, blood glucose test strips, and blood glucose meters. For instance, Medicare, the federal health insurance program in the US, covers approximately 80% of the cost of BGM devices for people with diabetes. Extensive research carried out by the analysts has also shown that the American Association of Diabetes Educators has released a reimbursement procedure for primary care practice, which states that the costs of medical services that are incurred by diabetic patients can be reimbursed through Medicare. Due to the availability of such reimbursement facilities, the sales of BGM devices has increased. 

Another key trend that fosters market growth is the recent increase in online marketing strategies. To increase the sales and brand equity, vendors are increasing their online marketing and promotional activities. Also, since online channels reduce the set-up and operational costs and provide easy access for the customers, the demand for online purchase of glucose meters is growing. Some of the leading vendors provide online services for purchasing blood glucose meters, blood glucose strips, and lancets. All these factors, together, intensify the level of market competition in the forthcoming years.

Competitive landscape and key vendors


February 10, 2017 | 76 Pages | SKU: IRTNTR11381

Global outlook of the tuberculosis (TB) drug market

Technavio’s market research analysts predict the global tuberculosis drug market to grow steadily during the forecast period and post a CAGR of more than 3% by 2021. This industry research report identifies the emergence of multidrug-resistant TB (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) strains to be one of the major factors that will have a positive impact on the growth of this market in the coming years. The recent years witnessed an increase in the emergence of drug-resistant TB, especially in the highly populated countries such as India and China. It has been observed by the Centers for Disease Control and Prevention (CDC) that XDR-TB is present across all regions of the world and is most prevalent in countries of the former Soviet Union and Asia. Countries such as the US, India, Japan are also witnessing an increase in the transmission of MDR-TB. This increase in TB infections will subsequently drive the demand for TB drugs in the coming years, in turn, aiding market growth.

This market research and analysis estimates that in terms of geographical regions, the Americas will be the major revenue contributor to the TB drugs market throughout the predicted period. Due to factors such as the reduction or stagnant funding for TB prevention efforts in the US, major states such as California, Florida, New York, and Texas reported an increase in the incidence rate of tuberculosis during 2015. This growing incidence rate of TB in the region will be the primary factor for the growth of the market in the Americas.

Competitive landscape and key vendors

The market is oligopoly in nature since there are a very few players who manufacture drugs for tuberculosis and is dominated by the major players such as Sanofi, Otsuka


February 10, 2017 | 91 Pages | SKU: IRTNTR11145

Overview of the global antifungal drugs market

Market research analysts at Technavio predict that the global antifungal drugs market will grow steadily during the next four years and post a CAGR of more than 3% by 2021. This market research analysis identifies the rising popularity of the over-the-counter (OTC) antifungal drugs for dermal infections as one of the primary growth factors for this antifungal medication market. With extensive advertisements and endorsements pharmaceutical companies are introducing several OTC drugs in the market for the treatment of dermal infections. These OTC drugs are cost-effective and are available as solutions, ointments, creams, powders, lotions, and aerosols. Since these OTC topical antifungal agents, including miconazole nitrate, butenafine hydrochloride, clotrimazole, tolnaftate, and terbinafine hydrochloride are effective in the treatment of mild to moderate fungal skin infections, the coming years will witness an exponential increase in the demand for antifungal medicines.

This market research and analysis estimates that in terms of geographical regions, the Americas will be the major revenue contributor to the antifungal pills market throughout the predicted period. The increasing incidences of infectious diseases in the US and the introduction of regulations that support the development of antifungal drugs in the Latin American countries will be the major factors driving the growth of the market in the coming years.

Competitive landscape and key vendors

The market is characterized by the presence of a number of antifungal drugs manufacturers and appears to be highly fragmented. The market is highly competitive and is dominated by the major


February 10, 2017 | 95 Pages | SKU: IRTNTR11919

Overview of the global pulmonary endoscopy devices market

According to the Technavio’s analyst, the global pulmonary endoscopy devices market is anticipated to grow at a steady rate and will post a CAGR of more than 4% during the forecast period. The growing popularity of minimally invasive procedures will drive the growth prospects for the global pulmonary endoscopy devices market for the next four years. The market is witnessing a huge shift from the conventional open surgeries towards minimally invasive surgeries using pulmonary endoscopy devices because the traditional methods involve various post-operation complications such as pain, blood clots, fatigue, muscle atrophy, infections, sore throat, nausea, and sleepiness. On the other hand, some of the major benefits associated with minimally invasive surgeries such as reduced cost and hospital stay, lower risks of post-operation infections, rapid results, and faster recovery period also fuels the adoption of pulmonary endoscopy devices in various medical facilities. Furthermore, the increasing effort of vendors on providing training for surgeons to perform endoscopic surgeries using these devices will further accelerate the acceptance of pulmonary endoscopy devices. Moreover, these devices are also used for treating people who are under critical conditions and cannot be operated using conventional open surgeries.

The growing shift towards the use of disposable endoscopy devices in developed countries will drive the growth prospects for the global pulmonary endoscopy devices market during the forecasted period. Some of the major factors responsible for the growing preference for disposable endoscope devices is to


February 10, 2017 | 103 Pages | SKU: IRTNTR11920

Overview of the global oxygen therapy devices market

According to the Technavio’s analyst, the global oxygen therapy devices market is anticipated to grow at a steady rate and will post a CAGR of close to 11% during the forecast period. The growing inclination of patients towards home healthcare will drive the growth prospects for the global oxygen therapy devices market until the end of 2021. The modern medicine and improvement in healthcare services and devices to manage respiratory diseases from home have propelled the demand for oxygen therapy devices in the market. For instance, home oxygen therapy (HOT) devices are suitable for people with mild to moderate respiratory disorders like chronic obstructive pulmonary disease (COPD) and asthma, whereas, PAP devices are suitable for people with obstructive sleep apnea (OSA) as they are employed in a familiar home setting. Furthermore, some of the major factors responsible for the growing demand of these devices and healthcare services is the reduction in healthcare expenditure and growing geriatric population who prefer home care over hospital stays.

In terms of geography, the Americas accounted for the majority market share during 2016 and will continue to dominate the market for the next four years. Some of the major factors responsible for the market’s growth in the region is the rise in disposable income, growing awareness about the availability of various treatment options for OSA and RDS


Pages